Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jingwen Yong"'
Autor:
JingWen Yong, JinFan Tian, Xin Zhao, XueYao Yang, MingDuo Zhang, Yuan Zhou, Yi He, XianTao Song
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Objective: This study explored the best treatment strategies for stable coronary artery disease (SCAD) patients with differing levels of ischemic severity. Methods: We conducted a comprehensive search of the PubMed, EMBASE, and Cochrane databases –
Externí odkaz:
https://doaj.org/article/d6e491958111435f8e6dfee085d13d52
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 12 (2021)
Background: Coronary artery disease (CAD) is the leading cause of death in advanced kidney disease. However, its best treatment has not been determined. Methods: We searched PubMed and Cochrane databases and scanned references to related articles. St
Externí odkaz:
https://doaj.org/article/38907c866bb04170b120984693faa106
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 7 (2020)
Objective: This study aims to investigate the impact of cardiovascular medications on the coronary flow reserve (CFR) in patients without obstructive coronary artery disease (CAD).Methods: We searched PubMed, EMBASE, and Cochrane databases from incep
Externí odkaz:
https://doaj.org/article/4b9869da63284320a7ee7c6ab3c3644a
Publikováno v:
Clinical Therapeutics. 44:1150-1159
This review of colchicine, an effective anti-inflammatory agent, examines whether the reduction in ischemic events produced by colchicine translates to a reduction in mortality, the optimal duration of treatment, and the patient populations that bene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::611a2539a6867340b56a82301fedf66e
https://doi.org/10.1016/j.clinthera.2022.06.009
https://doi.org/10.1016/j.clinthera.2022.06.009
Autor:
JingWen Yong, JinFan Tian, HuiJuan Zuo, JiaXin Cao, HuiHui Kong, Xin Zhao, XueYao Yang, HongJia Zhang, Yi He, XianTao Song
Publikováno v:
Microvascular Research. 147:104493
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1977d5a8740a3762567d18bf003c1be
https://doi.org/10.1016/j.mvr.2023.104493
https://doi.org/10.1016/j.mvr.2023.104493
Autor:
Xin Zhao, Xueyao Yang, Ziyu An, Libo Liu, Jingwen Yong, Haoran Xing, Rongchong Huang, Jinfan Tian, Xiantao Song
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 153
Multiple pathophysiological pathways are activated during the process of myocardial injury. Various cardioprotective strategies protect the myocardium from ischemia, infarction, and ischemia/reperfusion (I/R) injury through different targets, yet the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c093779cc0351643bbc8f4c8983e07cf
https://pubmed.ncbi.nlm.nih.gov/35750009
https://pubmed.ncbi.nlm.nih.gov/35750009
Autor:
Huihui Kong, Jing An, Jiaxin Cao, Zhenchao Tang, Jinfan Tian, Jingwen Yong, Xiantao Song, Yi He
Purpose The aim of this study was to evaluate the efficiency and safety of adenosine triphosphate (ATP) as a stress agent in a cohort of patients undergoing stress perfusion cardiac magnetic resonance imaging (CMR). Methods This retrospective study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::338bb1551bb9d948fd4cf501a3ee3cac
https://doi.org/10.21203/rs.3.rs-1145331/v1
https://doi.org/10.21203/rs.3.rs-1145331/v1
Background We investigated whether glycated haemoglobin A1c (HbA1c) could independently predict the decline in the myocardial perfusion reserve index (MPRI) in patients with coronary microvascular disease (CMD) by stress perfusion cardiac magnetic re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a0dcc44bcaccd4bc21259d14be82c48
https://doi.org/10.21203/rs.3.rs-814521/v1
https://doi.org/10.21203/rs.3.rs-814521/v1
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 12 (2021)
Therapeutic Advances in Chronic Disease
Therapeutic Advances in Chronic Disease
Background:Coronary artery disease (CAD) is the leading cause of death in advanced kidney disease. However, its best treatment has not been determined.Methods:We searched PubMed and Cochrane databases and scanned references to related articles. Studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::951d1bb5f0cc60f6aebba4d2e1d06781
https://doaj.org/article/38907c866bb04170b120984693faa106
https://doaj.org/article/38907c866bb04170b120984693faa106
Autor:
Ziyu An, Jinfan Tian, Yue Liu, Xin Zhao, Xueyao Yang, Jingwen Yong, Libo Liu, Lijun Zhang, Wenjian Jiang, Xiantao Song, Hongjia Zhang
Publikováno v:
Aging & Disease; Dec2022, Vol. 13 Issue 6, p1770-1785, 16p